Soft Tissue Sarcoma: Clinical Trials

Showing 20 trials
Titlesort icon Investigator
A Phase I Study Assessing the Effects of Food and Formulation on the Processing of KPT-330 in Patients with Sarcoma
[Protocol 13-145]
Gounder, Mrinal, MD
A Phase I Study of Dasatinib and Ipilimumab for Patients with Advanced GIST or Other Sarcomas
[Protocol 12-083]
D'Angelo, Sandra, MD
A Phase I Study of HDM201 in Patients with Advanced Cancers and a Normal TP53 Gene
[Protocol 14-139]
Hyman, David, MD
A Phase I Study of Humanized 3F8 Monoclonal Antibody in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
[Protocol 11-009]
Basu, Ellen, MD, PhD
A Phase I Study of Humanized 3F8 plus Interleukin-2 in Patients with High-Risk Neuroblastoma and GD2-Positive Tumors
Relapsed/Refractory
[Protocol 12-116]
Roberts, Stephen, MD
A Phase I Study of PLX3397 in Patients with Advanced Solid Tumors
[Protocol 12-156]
Tap, William, MD
A Phase I Study of SAR405838 in Patients with Advanced Cancer
[Protocol 13-093]
Dickson, Mark, MD
A Phase I/II Study of Sunitinib in Young Patients with Advanced Gastrointestinal Stromal Tumors
Newly Diagnosed & Relapsed/Refractory
[Protocol 12-226]
Magnan, Heather, MD
A Phase IA/IB Study of RO5509554 Alone and with Paclitaxel in Patients with Advanced Solid Tumors
[Protocol 14-086]
D'Angelo, Sandra, MD
A Phase IB Study of BGJ398 plus Imatinib in Patients with Persistent Gastrointestinal Stromal Tumor
[Protocol 14-140]
Tap, William, MD
A Phase Ib/II Study of MEK162 with Imatinib in Patients with Untreated Advanced Gastrointestinal Stromal Tumor
[Protocol 13-162]
Chi, Ping, MD, PhD
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
Newly Diagnosed & Relapsed/Refractory
[Protocol 11-183]
Trippett, Tanya, MD
A Phase II Study of Irinotecan and Temozolomide in Combination with Existing High-Dose Chemotherapy for Patients Newly Diagnosed with Ewing Sarcoma
[Protocol 13-068]
Magnan, Heather, MD
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194]
Dickson, Mark, MD
A Phase II Study of Whole-Lung IMRT in Children and Adults with Synovial Sarcoma that Spread to the Lungs
[Protocol 14-075]
Wolden, Suzanne, MD
A Phase III Study of Doxorubicin Alone or in Combination with TH-302 in Patients with Locally Advanced Inoperable or Metastatic Soft-Tissue Sarcoma
[Protocol 11-203]
Tap, William, MD
A Phase III Study of Preoperative Radiotherapy plus Surgery versus Surgery Alone for Patients with Retroperitoneal Sarcoma
[Protocol 14-051]
Crago, Aimee, MD
A Phase III Study of Sorafenib versus Placebo in Patients with Desmoid Tumors
[Protocol 14-015]
Gounder, Mrinal, MD
A Pilot Study of Genetically Engineered NY-ESO-1-Specific T Cells in Children and Adults with Persistent Synovial Sarcoma
[Protocol 13-236]
D'Angelo, Sandra, MD
A Pilot Trial of Irinotecan, Temozolomide, and Bevacizumab plus High-Dose Chemotherapy for Newly Diagnosed Patients with Desmoplastic Small Round Cell Tumor
[Protocol 10-091]
Magnan, Heather, MD